Latest Research On Acupuncture Market (2018-2023) | trends, Global Analysis and Forecast

 Acupuncture is an alternative medicine approach which uses needles that are inserted into the skin at acupuncture points to treat several diseases. Acupuncture has notably emerged from China as a component of their health care system. The overall working of acupuncture is based on the foundation that there are patterns of energy flow, Qi, through the body which are important for health, and acupuncture corrects the imbalances of flow at identifiable points close to the skin. The market is expected to expand with a CAGR of 14.50 percent while earning revenues worth USD 55323.8 million in the duration of the forecast period from 2018 to 2023.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6139

The market growth is fuelled by factors such as the growing incidence of gynecological disorders such as menstrual issues, PMS, PCOS, pregnancy complaints, menopause, infertility, and chronic pain disorders which are encouraging the development of the acupuncture market globally. Additionally, the rising occurrence of chronic diseases such as fibromyalgia and migraines which lead to health complications such as insomnia, body pain, and psychological illness will boost the progress of the acupuncture market globally. The escalating demand for non-invasive and painless acupuncture has led to an increase in the level of advancements in acupuncture therapy. The advent of technically advanced acupuncture treatments such as the usage of laser devices and electro acupuncture is projected to improve the development of the acupuncture market internationally for the duration of the forecast period. Moreover, many notable competitors are getting involved in the development and manufacturing of laser and electro acupuncture devices.

Increasing health complications in the elderly population such as sleep disturbances, body pain, and emotional disorders have also powered the development of the market. The mounting geriatric population worldwide is anticipated to influence the acupuncture market in the forecast period. The intensifying demand for alternative and complementary medicine like acupuncture has enhanced the funding scenario for the market which can be a vast opportunity for the expansion of the market through the forecast period. The funding from market contenders and new entrants in the market is likely to add to the market’s growth in the forecast period.

Segmental Analysis

The acupuncture market is segmented on the basis of application, end user, product & services. The segmentation of the market on the basis of product & services comprises of services and products. The service segment is further segmented into Japanese acupuncture, traditional Chinese medicine, auricular, Korean hand acupuncture, and scalp acupuncture, moxibustion, non-insertion acupuncture, cupping, and others. The product segment is additionally segmented into suction cups, needles, rod lasers, laser needle, and laser pens, electro-acupuncture device, and others. The needles are additionally sub segmented into modern needles and traditional needles. The service segment controls the acupuncture market by product & services due to the growing preference given to traditional acupuncture therapies. By application, the market is segmented into gynecological disorders, pain syndrome illnesses, psychological illnesses, and others. Pain syndrome illnesses controls the major market share of 33.5 percent over the forecast period, and it is also projected to develop at a CAGR of 14.04 percent through the forecast period. The end user segment of the market is segmented into hospitals & specialty clinics, wellness center, and research & academic institutes. Wellness Centre will possibly control the global acupuncture market due to a huge number of wellness center involved in acupuncture therapies and the rising preference for acupuncture as alternative medicine.

 

Detailed Regional Analysis 

The regional analysis of the market observes that the European region is expected to control the prime market share in the acupuncture market globally and is projected to develop at a CAGR of 13.53 percent during the forecast period. The market development is accredited to the intensifying occurrences of chronic diseases and growing preference for acupuncture therapies amongst the European population. Furthermore, the existence of major market contenders significantly adds to the market growth in the region. Additionally, the escalating insurance coverage in nations like France, Austria, Spain, and others, by other private companies will offer a promising backdrop for the market growth in the European region.

The Asia Pacific region is likely to be the most swiftly increasing region in the acupuncture market globally and is anticipated to develop at a CAGR of 15.02 percent for the duration of the assessment period. The growth of the Asia Pacific acupuncture market is credited to the existence of nations such as Korea, China, and Japan which has a high adoption rate for acupuncture therapies. Additionally, the growing number of companies manufacturing the acupuncture products and the rising prevalence of chronic diseases is powering the market growth in this region.

Competitive Analysis

Several competitors are functioning in the acupuncture market globally. Many organizations, particularly in the European and Asia Pacific regions, have their manufacturing units, while some organizations are also involved in import from other regions. As the Asia Pacific is one of the most rapidly rising markets, firms are grasping the chances that are available and are keenly expanding their units in this region. However, the acupuncture market is presently controlled by a few players. The major competitors outlined in the report comprises of Zepter International, schwa-medico GmbH, MKW Lasersystem GmbH, Wuxi Jiajian Medical Instruments Co., Ltd, Cymedics GmbH & Co. KG, 3B Scientific GmbH, Kanson, SEIRIN Corporation, Asia med GmbH, Qingdao Great Fortune Co. Ltd, and AcuMedic Ltd.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

key Trends On Diagnostic Electrocardiograph (ECG) Market Size by Top Companies and Demand

 Market Analysis 

The global diagnostic electrocardiograph (ECG) market is likely to touch USD 10,487.24 million at a 6.72% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR). Diagnostic electrocardiograph, simply put, is a test that is utilized to detect electrical signals which the heart produces each time it beats. Smart ECG monitors, Holter monitors, event monitors, mobile cardiac telemetry devices, implantable loop recorders, stress ECG devices, and resting ECG devices are the different types of the diagnostic electrocardiograph. 

Get Free PDF @https://www.marketresearchfuture.com/sample_request/8787

Various factors are adding to the global diagnostic electrocardiograph market growth. Such factors, according to the new MRFR report, include increasing expenditure by market players in research and development to create novel ECG devices, technological advances in wearable devices and wireless monitoring, and an increase in the rate of lifestyle diseases. Additional factors adding market growth include the developing healthcare infrastructure, increasing geriatric population, and rising cases of cardiovascular diseases. 

On the contrary, irregular reimbursement policies, uncertainty in economic circumstances and market saturation, and scarcity of skilled professionals are factors that may limit the diagnostic electrocardiograph market growth over the forecast period

Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global diagnostic electrocardiograph market report based on end user, product type, and lead type. 

By product type, the diagnostic electrocardiograph market is segmented into smart ECG monitors, Holter monitors, event monitors, mobile cardiac telemetry devices, implantable loop recorders, stress ECG devices, and resting ECG devices. Of these, the resting ECG devices segment will lead the market over the forecast period for its increasing use in hospitals worldwide. 

By lead type, the diagnostic electrocardiograph market is segmented into single-lead ECG devices, 6-lead ECG devices, 3-lead ECG devices, 5-lead ECG devices, and 12-lead ECG devices. Of these, the 3-lead ECG devices segment will dominate the market over the forecast period for its wide applications in various cardiac diagnostic tests. 

By end user, the diagnostic electrocardiograph market is ambulatory surgical centers, hospitals and clinics, and others. Of these, the ambulatory surgical centers segment will have a major share in the market over the forecast period for its ample recognition in developing countries. 

Regional Analysis 

Based on the region, the global diagnostic electrocardiograph market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have lions share in the market over the forecast period. Surging demand for medical devices coupled with rising cases of cardiovascular diseases like arrhythmia and stroke, are adding to the growth of the market in the region. 

The global diagnostic electrocardiograph market in Europe is predicted to hold the second-largest share over the forecast period. Rising acceptance of new diagnostic products and increasing geriatric population are adding to the growth of the market in the region. 

The global diagnostic electrocardiograph market in the APAC region is predicted to grow at a fast pace over the forecast period. Rising prevalence of heart diseases like stroke and increasing per capita disposable income are the factors that are adding to the market growth in the region. 

The global diagnostic electrocardiograph market in the MEA is predicted to have steady growth over the forecast period. The increasing burden of cardiac diseases and gradually developing healthcare infrastructure are factors that are adding to the market growth in the region. 

Key Players

Eminent players profiled in the global diagnostic electrocardiograph market report include VectraCor, Inc. (US), Innomed Medical Inc. (Hungary), Norav Medical (US), Cardioline SpA (Italy), Edan Instruments, Inc. (China), BTL (US), Fukuda Denshi (Japan), BPL Medical Technologies (India), ACS Diagnostics (US), Schiller (Switzerland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Hillrom Services, Inc. (US), Nihon Kohden Corporation (Japan), Koninklijke Philips N.V. (Netherlands), and General Electric Company (US). 

Read More@ https://www.marketresearchfuture.com/reports/diagnostic-electrocardiograph-market-8787

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

News: Medication management Market Trends. global Size & share by 2023

 Medication management is an approach to understand the purpose of the medications and its timely administration in the correct manner. Adherence to a medication regimen is vital especially for geriatrics and patients with multiple chronic conditions. Failing to comply with a medication regimen is often cited as a paramount reason why patients are readmitted in the hospital following discharge. 

Free Sample PDF Avvailable Here !! https://www.marketresearchfuture.com/sample_request/7187

In such scenarios, medication management services have been proving to be effective providing medication reconciliation, medication therapy management, patient/family education on medications and medication set-up simulations for the patient. Many home care providers have also started to make in-home medication management a core component of their operations.

For many aging populaces, relinquishing medication management services to a third party is one of the easier options. And it’s becoming a market differentiator among seniors looking for reliable, competent and service-minded companies to manage one of their most critical medical issues. 

Also, for the patients suffering from chronic illnesses who usually have to administer and monitor 10-12 medications per day, resorting to smart medication management systems which promote their wellbeing becomes useful. 

As a result, the uptake of medication management is growing which, in turn, is increasing the size of the global medication management market. Moreover, the recent trend of prescription medicine is escalating the market on the global platform. 

Considering the colossal growth, the market perceives currently; Market Research Future (MRFR), in its recently published study report asserts that the global medication management market will grow exponentially by 2023, registering approximately 13.4% CAGR throughout the forecast period (2018 – 2023).

Additional factors helping the market to boost further are the ever-increasing population, geriatric populaces, and increased occurrence of chronic diseases which are growing the need for the medication management solutions.

Advancements in IT technology and increasing uptake of healthcare IT for efficient management are expected to increase the size of the market. Furthermore, the rising government supports and the need for curtail healthcare costs without compromising the quality of care are some of the factors impacting the growth of the market, positively. 

On the other hand, factors such as high software implementation and service maintenance costs are impeding the growth of the market. Nevertheless, the advantages that medication management offers allowing the consolidation of all expenses which consequently saves the further cost of patient care is expected to act as a major tailwind supporting the growth of the market. 

 for care management solutions.  Moreover, the increasing healthcare expenditures are escalating the market on the global platform, increasing the need to curtail cost without compromising the quality of care.

 

Global Medication Management Market – Segmentation

For ease of understanding, the MRFR analysis has been segmented into five key dynamics: -

By Systems : Computerized Physician Order Entry Systems, Administration Software, Clinical Decision Support Systems, Inventory Management Systems, Automated Dispensing Systems, and Assurance Systems among others. 

By Services : Point-of-Care Verification Services and Adverse Drug Effects (ADE) Surveillance Services among others. 

By Mode of Delivery : Web-based Solutions, On-premise Solutions, and Cloud-based Solutions among others.

By End-user : Hospitals and Pharmacies among others.

By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World.

 

Medication Management Market – Regional Analysis

The North American region, heading with the presence of numerous key players is estimated to retain its dominance over the global medication management market. This region accounts for the best of the medical facilities around the world, and so is the higher rate of patients which along with the robust economy and high healthcare expenditure drive the medication management market in the region. 

Furthermore, the increasing number of polypharmacy, hospitals, and ambulatory centers alongside the well-developed technology drive the market growth in the region, meeting the higher demand of a vast patient population. 

The medication management market in the European region accounts for the next-largest market share, globally. Factors allowing the market to substantiate include the increasing demand for management software & platforms, strong government support, and availability of funds among others. Western European region backed by the presence of well-developed economies such as the U.K., Germany, and France holds a significant share in the regional market. Indeed, the resurging economy is playing a vital role in the growth of the market, making the high cost of medication affordable and increasing per capita income in this region. 

The Asia Pacific medication management market has emerged as a profitable market, globally. Factors such as the rapidly proliferating healthcare sector that is led by the improving economy, the increasing number of players, increasing government’s support and foreign investments, and vast technological advancements are impacting the regional market, positively. Additionally, the growing number of patients suffering from chronic diseases alongside the increasing per capita healthcare expenditure provide impetus to the growth of the market.

The Asia Pacific together accounts for over 41% of the global population, and most of the APAC countries are in the developing phase which leads to providing immense opportunities for the market players. Larger countries such as China and India backed by the densely populated area are considered as the biggest market for the Medication Management products in the region.

 

Global Medication Management Market – Competitive Analysis 

The medication management market appears fiercely competitive with the presence of several large and small players. The key strategies traced from the analysis of recent market developments include agreement & partnership, product launch, acquisition, and expansion.  International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional players to compete with them.

Major Players:

Key players leading the global medication management market include Mckesson Corporation, Allscripts Healthcare 0Electric Company, Medical Information Technology, Inc., Optum Inc., Omnicell, Inc., QuadraMed Affinity Corporation, and Siemens Ltd among others.

Industry, Innovation & Related News 

March 06, 2019 ---- BrightSpring Health Services (the US) a leading provider of comprehensive home and community-based health services announced its merge with the PharMerica (the US), a pharmacy powerhouse to position itself to lead the medication management, potentially.

BrightSpring hopes to effectively address medication needs while also providing caregiver services by providing its clients the right medications suiting their ailments in a timely and reliable manner and then helping to make sure they do so consistently. 

The merging deal will give BrightSpring a footprint with difficult-to-top proximity to the patients and clients it serves including behavioral health and specialty populations, along with older adults. KKR an affiliate of Walgreens Boots Alliance Inc. and a global investment firm had recently acquired BrightSpring (formerly ResCare) as part of the deal. 

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/medication-management-market-7187

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

Healthcare Contract Manufacturing Market Size, Key Insights Based on Applications, Material and Regional Demand 2020

 Global Healthcare Contract Manufacturing Market Research Report: Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

Market Scope

The global healthcare CMO market had touched the valuation of USD 129.91 billion in 2016, estimates Market Research Future (MRFR). It is projected to attain a CAGR of 9.86% during the forecast period (2017–2023), Growth Drivers and Top Restraints 

Growth Factors and Key Challenges 

The data analysts opine that the worldwide healthcare contract manufacturing market is expanding at a moderate but healthy rate. The chief factors backing the market growth include competition among companies with respect to the production and trade that favor CMO and the patent protection expiration of significant medical devices as well as drugs. Also, with both the contract manufacturers and clients reaping benefits and the agile form of manufacturing boosts market growth significantly. 

Read More @ https://www.marketresearchfuture.com/sample_request/5637 

Developing regions like Asia Pacific, Latin America and Middle East and Africa are experiencing potent growth of the biotechnology and pharmaceutical sectors. Several government bodies within these regions lend strong support in the form of numerous programs, conferences, initiatives as well as funding. The rapidly expanding pharmaceutical and biotechnology sectors lead to rise in demographic and economic growth along with surge in healthcare expenditures. On top of this, enhancement in the public-private healthcare funding has led to market growth in recent years. Therefore, developing areas across the globe are presumed to offer numerous growth opportunities to the healthcare CMO market in the following years.

The healthcare contract manufacturing market’s growth has been striking in the last few years owing to the numerous advantages offered by several international contract manufacturing companies. These companies offer a host of services to the pharmaceutical, medical device and biopharmaceutical companies. The pharmaceutical and biopharmaceutical companies enjoy numerous services by the CMO, whether it is the production of small amounts of materials for research and development (R&D) activities or huge funding for clinical study and commercialization.

Market Segmentation 

The worldwide healthcare contract manufacturing market has been segmented on the basis of type, service type, and industry.

The type-wise segments are sterile and non-sterile. Non-sterile is believed to have the fastest growth rate of 10.0% from 2017 to 2023.

Depending on the service type, the market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.

The industries mentioned in the report are pharmaceutical, medical device, and biopharmaceutical.

Regional Analysis 

Europe, Middle East and Africa, Asia Pacific and the Americas are the key markets for healthcare contract manufacturing. 

The Americas has been identified as the leading healthcare contract manufacturing market, backed by high investment in healthcare and the presence of strong economy. The rising focus of research institutions on advancement of technology also benefits the regional market. Data experts note the rising focus of the contract manufacturers on the upgradation of their factories as well as manufacturing capabilities. As a result of cost-efficient models and advanced manufacturing units, the healthcare contract manufacturing market in the region is projected to expand considerably in the near future. 

Europe is the second-most profitable market for healthcare contract manufacturing owing to the growing support from the governments and the high spending on healthcare. The Organization for Economic Co-operation and Development (OECD) reports that in 2014, the healthcare expenditure in Germany was around EUR 321 billion whereas France had the second highest healthcare expenditure of EUR 237 billion that year.

Growing at the fastest rate, Asia Pacific seems to possess lot of potential due to the high number of developing nations like India and China. These emerging economies are stimulating the growth of the healthcare contract manufacturing market, with the presence of highly developed healthcare infrastructure and the consistently advancing healthcare technology. 

Middle East & Africa, with the least market share, lags behind due to less availability of medical facilities and poor development of the healthcare sector. But, countries like Kuwait and Qatar are striving to develop their medical facilities, which will have a positive impact on the overall regional market in the subsequent years.

Key Vendors

The key vendors identified by MRFR include Lonza Ag, Catalant, Patheon, Mylan, Teva Pharmaceutical Industries, Benchmark Electronics, Vetter Pharma International, AbbVie, Boehringer Ingelheim, Aesica Pharmaceuticals, Grifols International, S.A, Hamilton Company, Sanmina Corporation, Flex Ltd, Forefront Medical Technologies, Evonik Industries to name a few.

Latest Developments 

April 2019

Catalent will be acquiring Paragon Bio-services, a contract manufacturing organization with focus on viral vectors that are used in gene therapies, for the cost of USD 1.2 billion.

Read More @ https://www.marketresearchfuture.com/reports/healthcare-contract-manufacturing-market-5637 ​​​​​​​

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:        

Akash Anand             

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

News: Artificial Intelligence in Drug Discovery Market 2020: Demand, Trends and Forecast

 The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height. 

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393 

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes. 

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery. 

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market. 

Major Players: 

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others. 

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics; 

By Product Type       : Services and Software. 

By Molecule Type: Large and Small Molecules.

By Technology         : Machine Learning, Deep Learning, and others. 

By Indication             : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others. 

By Application          : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others. 

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others. 

By Regions                : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

 

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth. 

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market. 

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market. 

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket. 

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI Drug discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

 

AI in Drug Discovery Market   - Competitive Analysis 

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.  

read more@ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:        

Akash Anand             

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

Anti-Venom Market 2020- Analysis and Research Report, Size, Share and Forecast

 Anti-Venom Market Driven by Enhancing Regulatory Framework

The recent report by Market Research Future (MRFR) predicts the global anti-venom market value will be expanding with a healthy CAGR of 6.5% over the forecast period (2017–2023).

Biotechnology, as well as the healthcare industry, is noting a considerable demand from developing nations globally. The prominent reason behind the strong growth of the anti-venom market is the growing demand for anti-venom treatment, as it is the only authorized treatment for snake bite, without any alternative treatment available. Moreover, violation of forest lands for housing and agricultural needs has gotten humans close to poisonous animals and insects, thereby increasing the prevalence of venomous bites. In addition, the prevalence of snake bites, scorpion bites, as well as other animal or insect bites like fish stings is an additional factor playing a major role in the anti-venom market growth.

Various research and development (R&D) activities taking place continuously that provide advanced drugs and standard treatment for poisonous insect bite further uplifts the market position of anti-venom. Growing demand for anti-venoms in the emerging countries is encouraging the prominent players to penetrate these markets, such as in India and Africa in order to offer anti-venom products at a cost-effective price. This is yet another driver responsible for the growth of the global anti-venoms market.

In contrast, the high cost of anti-venom due to the high production cost in a few regions could hamper the growth of the anti-venom market. However, the rapid development of the economic conditions around the world is creating massive opportunities for the expansion of the anti-venom market. The improving economy is increasing the individual per capita income, which will increase the spending capacity on health care. The contribution of the developing countries of Asia Pacific as well as the Middle East coupled with the growing population and increasing capita income will foster the growth of the market.

Segmentation 

The global anti-venom market is segmented on the basis of type, type of species, mode of action, product type, and end user.

The global anti-venom market, by type, is categorized into polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.

By species type, the global anti-venom market is segmented into snakes, scorpions, spiders, and others. The snake segment is further classified as a common cobra, common krait, Russell Viper, and others.

Based on the mode of action, the global anti-venom market is divided into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.

The product types in the global anti-venom market include snake anti-venom, scorpion anti-venom, spider anti-venom, and others.

End-user-wise, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Regional Analysis

The regions among which the global anti-venom market is segmented into are Asia Pacific, Europe, Americas, and the Middle East and Africa.

At a global level, the Americas will be leading the anti-venom market in the coming years on account of the increasing cases of snake bites, as well as scorpion bites coupled with the high healthcare expenditure.

Europe will be securing the second position in the global anti-venom market, due to the strong financial support by the government for research and development along with the improvement in reimbursement scenario, driving the Europe anti-venom market. As per the data furnished by Eurostat, it is noted that among all the EU Member States, the highest value of healthcare expenditure has been recorded in Germany in the year 2014, which was around EUR 321 billion, followed by France at the value of EUR 237 billion and United Kingdom valued at EUR 223 billion. In the year 2016, the R&D expenditure for the pharmaceutical industry was at the value of EUR 35000 million, stated by the European Federation of Pharmaceutical Industries and Association.

Furthermore, Asia Pacific is touted to be the fastest growing anti-venom market, resulting from the massive patient pool coupled with the increasing advancements in pharmaceuticals. As per the Indian Brand Equity Foundation (IBEF), the generics market in the country was around USD 26.1 billion in the year 2016. Moreover, according to the statistics by the World Health Organization (WHO), around 2.8 million people are bitten by snakes, and close to 46 900 people succumb to snakebites every year.

Lastly, the market in the Middle East and Africa account for the lowest share of the global market owing to the restricted economic development, lack of technical knowhow, and poor medical facilities.

Competitive Landscape

Thermo Fisher Scientific, Ypsomed Holding AG, Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Allison Medical, Inc., cHill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Allison Medical, Inc., Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Novo Nordisk A/s, UltiMed, Inc., Boston Scientific Corporation, are some of the leading companies in the global anti-venom market.

Industry Update 

February 2019 – Kenya’s Ministry of Health is set to produce anti-snake venom for ensuring a sustainable supply, in addition to developing few policies, guidelines as well as processes for identifying cheaper high-quality brands for licensing. The products will be procured and distributed to public health facilities by the country’s medical supplies authority.

Read More @https://www.marketresearchfuture.com/reports/anti-venom-market-5859 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Latest Resarch On Neurovascular Devices Market 2020, News, Demand, Global Analysis by Top Companies

 Neurovascular Devices Market Synopsis:

Increased incorporation of advanced technology in the healthcare sector has led to the development of various medical devices that can be utilized to treat complex medical conditions. Neurovascular devices are advanced medical devices that are used to treat various neurovascular diseases that can affect the central nervous system and associated vascular system. Market Research Future (MRFR) has published a report stating that the global neurovascular devices market is marked to expand at a noteworthy CAGR of 8.8% during the forecast period of 2017-2023.

Free Sample PDF Available Here !!https://www.marketresearchfuture.com/sample_request/5544

High prevalence of neurovascular diseases in developed and developing regions as a result of changing lifestyle and increased healthcare expenditure are majorly fueling the expansion of the global neurovascular devices market during the assessment period. Increased research and development expenditure and rapid technological advancement in the healthcare sector are also propelling the expansion of the global neurovascular devices market. However, poor economic conditions and lack of primary healthcare facilities are likely to restrain the expansion of the global neurovascular devices market during the forecast period. 

Neurovascular Devices Market Segmentation:

The global market for neurovascular devices has been segmented on the basis of product, therapeutic application, and end-user. Based on product, the neurovascular devices market has been segmented into aneurysm coiling and embolization devices, neurothrombectomy devices, support device, and cerebral balloon angioplasty and stenting systems. The aneurysm coiling and embolization devices segment has been sub-segmented into embolic coils, flow diversion devices, and liquid embolic. The embolic coils sub-segment includes detachable coils and pushable coils. The neurothrombectomy devices segment has been sub-segmented into retrieval systems and suction & aspiration devices. The support device segment has been sub-segmented into microguidewires and microcatheters. The cerebral balloon angioplasty & stenting systems segment has been sub-segmented into embolic protection systems and carotid artery stents. The embolic protection systems segmented is further segmented into balloon occlusion devices and distal filter devices. Based on therapeutic application, the neurovascular devices market has been segmented into hemorrhagic stroke and ischemic strokes. Based on end-users, the neurovascular devices market has been segmented into hospitals & clinics, and ambulatory surgical units.

Neurovascular Devices Market Regional Analysis:

Geographically, the global neurovascular devices market has been segmented into four major regions such as Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is dominating the global neurovascular devices market owing to the high prevalence of neurovascular diseases, increased healthcare expenditure as a result of increased disposable income, easy adoption of technologically advanced medical devices and the presence of well-developed healthcare sector in this region. The Europe region commands second largest share in the global neurovascular devices market owing to the rapid technological advancement and increased research and development activities for the introduction of advanced medical devices in the developed healthcare sector of this region. The neurovascular devices market in the Asia Pacific region is expanding at the fastest growth rate owing to the increased awareness regarding the availability of advanced medical devices and increased government funding for the development of healthcare sector in this region. Whereas, poor economic condition and absence of primary healthcare facilities in the underdeveloped countries are restraining the growth of the neurovascular devices market in the Middle East and Africa region.     

 Neurovascular Devices Market Top Key Players:

The key players profiled by MRFR that are operating in the global neurosurgery devices market share are Stryker, Medtronic, Johnson & Johnson Services, Inc., TERUMO CORPORATION, Abbott, Merit Medical Systems, Inc., Medikit co., ltd., Penumbra, Inc., MicroPort Scientific Corporation, Evasc, Rapid Medical, Neuravi, W. L. Gore & Associates, Inc., OxfordEndovascular, Sensome, Blockade Medical, LLC., Delaware Corporation, Secant Group, LLC, and Gynesonics. The players in the global neurovascular devices market are aiming towards expansion of their businesses on global level by introducing advanced devices through increased research and development expenditure and strategic mergers and acquisitions are aiding these players in maintaining their dominance in the highly competitive environment of the global neurovascular devices market.

Read More!! https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.